Chapter/Section Purchase

1 Study Coverage
1.1 Kidney Transplant Rejection Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Azathioprine
1.2.3 Cortina
1.2.4 Cyclophosphamide
1.2.5 Cyclosporin A
1.2.6 Other
1.3 Market by Application
1.3.1 Global Kidney Transplant Rejection Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Kidney Transplant Rejection Therapeutics Sales Estimates and Forecasts 2017-2028
2.2 Global Kidney Transplant Rejection Therapeutics Revenue Estimates and Forecasts 2017-2028
2.3 Global Kidney Transplant Rejection Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Kidney Transplant Rejection Therapeutics Sales by Region
2.4.1 Global Kidney Transplant Rejection Therapeutics Sales by Region (2017-2022)
2.4.2 Global Sales Kidney Transplant Rejection Therapeutics by Region (2023-2028)
2.5 Global Kidney Transplant Rejection Therapeutics Revenue by Region
2.5.1 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2017-2022)
2.5.2 Global Kidney Transplant Rejection Therapeutics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Kidney Transplant Rejection Therapeutics Sales by Manufacturers
3.1.1 Global Top Kidney Transplant Rejection Therapeutics Manufacturers by Sales (2017-2022)
3.1.2 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Kidney Transplant Rejection Therapeutics in 2021
3.2 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers
3.2.1 Global Kidney Transplant Rejection Therapeutics Revenue by Manufacturers (2017-2022)
3.2.2 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Kidney Transplant Rejection Therapeutics Revenue in 2021
3.3 Global Kidney Transplant Rejection Therapeutics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Kidney Transplant Rejection Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Kidney Transplant Rejection Therapeutics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Kidney Transplant Rejection Therapeutics Sales by Type
4.1.1 Global Kidney Transplant Rejection Therapeutics Historical Sales by Type (2017-2022)
4.1.2 Global Kidney Transplant Rejection Therapeutics Forecasted Sales by Type (2023-2028)
4.1.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Type (2017-2028)
4.2 Global Kidney Transplant Rejection Therapeutics Revenue by Type
4.2.1 Global Kidney Transplant Rejection Therapeutics Historical Revenue by Type (2017-2022)
4.2.2 Global Kidney Transplant Rejection Therapeutics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Type (2017-2028)
4.3 Global Kidney Transplant Rejection Therapeutics Price by Type
4.3.1 Global Kidney Transplant Rejection Therapeutics Price by Type (2017-2022)
4.3.2 Global Kidney Transplant Rejection Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Kidney Transplant Rejection Therapeutics Sales by Application
5.1.1 Global Kidney Transplant Rejection Therapeutics Historical Sales by Application (2017-2022)
5.1.2 Global Kidney Transplant Rejection Therapeutics Forecasted Sales by Application (2023-2028)
5.1.3 Global Kidney Transplant Rejection Therapeutics Sales Market Share by Application (2017-2028)
5.2 Global Kidney Transplant Rejection Therapeutics Revenue by Application
5.2.1 Global Kidney Transplant Rejection Therapeutics Historical Revenue by Application (2017-2022)
5.2.2 Global Kidney Transplant Rejection Therapeutics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Kidney Transplant Rejection Therapeutics Revenue Market Share by Application (2017-2028)
5.3 Global Kidney Transplant Rejection Therapeutics Price by Application
5.3.1 Global Kidney Transplant Rejection Therapeutics Price by Application (2017-2022)
5.3.2 Global Kidney Transplant Rejection Therapeutics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Kidney Transplant Rejection Therapeutics Market Size by Type
6.1.1 North America Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028)
6.1.2 North America Kidney Transplant Rejection Therapeutics Revenue by Type (2017-2028)
6.2 North America Kidney Transplant Rejection Therapeutics Market Size by Application
6.2.1 North America Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028)
6.2.2 North America Kidney Transplant Rejection Therapeutics Revenue by Application (2017-2028)
6.3 North America Kidney Transplant Rejection Therapeutics Market Size by Country
6.3.1 North America Kidney Transplant Rejection Therapeutics Sales by Country (2017-2028)
6.3.2 North America Kidney Transplant Rejection Therapeutics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Kidney Transplant Rejection Therapeutics Market Size by Type
7.1.1 Europe Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028)
7.1.2 Europe Kidney Transplant Rejection Therapeutics Revenue by Type (2017-2028)
7.2 Europe Kidney Transplant Rejection Therapeutics Market Size by Application
7.2.1 Europe Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028)
7.2.2 Europe Kidney Transplant Rejection Therapeutics Revenue by Application (2017-2028)
7.3 Europe Kidney Transplant Rejection Therapeutics Market Size by Country
7.3.1 Europe Kidney Transplant Rejection Therapeutics Sales by Country (2017-2028)
7.3.2 Europe Kidney Transplant Rejection Therapeutics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Kidney Transplant Rejection Therapeutics Market Size by Type
8.1.1 Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028)
8.1.2 Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Type (2017-2028)
8.2 Asia Pacific Kidney Transplant Rejection Therapeutics Market Size by Application
8.2.1 Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028)
8.2.2 Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Application (2017-2028)
8.3 Asia Pacific Kidney Transplant Rejection Therapeutics Market Size by Region
8.3.1 Asia Pacific Kidney Transplant Rejection Therapeutics Sales by Region (2017-2028)
8.3.2 Asia Pacific Kidney Transplant Rejection Therapeutics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Kidney Transplant Rejection Therapeutics Market Size by Type
9.1.1 Latin America Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028)
9.1.2 Latin America Kidney Transplant Rejection Therapeutics Revenue by Type (2017-2028)
9.2 Latin America Kidney Transplant Rejection Therapeutics Market Size by Application
9.2.1 Latin America Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028)
9.2.2 Latin America Kidney Transplant Rejection Therapeutics Revenue by Application (2017-2028)
9.3 Latin America Kidney Transplant Rejection Therapeutics Market Size by Country
9.3.1 Latin America Kidney Transplant Rejection Therapeutics Sales by Country (2017-2028)
9.3.2 Latin America Kidney Transplant Rejection Therapeutics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size by Type
10.1.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Type (2017-2028)
10.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size by Application
10.2.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Application (2017-2028)
10.3 Middle East and Africa Kidney Transplant Rejection Therapeutics Market Size by Country
10.3.1 Middle East and Africa Kidney Transplant Rejection Therapeutics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Kidney Transplant Rejection Therapeutics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Limited
11.1.1 CSL Limited Corporation Information
11.1.2 CSL Limited Overview
11.1.3 CSL Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Limited Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Limited Recent Developments
11.2 Digna Biotech, S.L.
11.2.1 Digna Biotech, S.L. Corporation Information
11.2.2 Digna Biotech, S.L. Overview
11.2.3 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Digna Biotech, S.L. Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Digna Biotech, S.L. Recent Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Corporation Information
11.3.2 GlaxoSmithKline Plc Overview
11.3.3 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GlaxoSmithKline Plc Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Plc Recent Developments
11.4 Grifols, S.A.
11.4.1 Grifols, S.A. Corporation Information
11.4.2 Grifols, S.A. Overview
11.4.3 Grifols, S.A. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Grifols, S.A. Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Grifols, S.A. Recent Developments
11.5 Hansa Medical AB
11.5.1 Hansa Medical AB Corporation Information
11.5.2 Hansa Medical AB Overview
11.5.3 Hansa Medical AB Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hansa Medical AB Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hansa Medical AB Recent Developments
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Corporation Information
11.6.2 Kyowa Hakko Kirin Overview
11.6.3 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Kyowa Hakko Kirin Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kyowa Hakko Kirin Recent Developments
11.7 Mabtech Limited
11.7.1 Mabtech Limited Corporation Information
11.7.2 Mabtech Limited Overview
11.7.3 Mabtech Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mabtech Limited Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mabtech Limited Recent Developments
11.8 Magnus Life Ltd
11.8.1 Magnus Life Ltd Corporation Information
11.8.2 Magnus Life Ltd Overview
11.8.3 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Magnus Life Ltd Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Magnus Life Ltd Recent Developments
11.9 Noorik Biopharmaceuticals AG
11.9.1 Noorik Biopharmaceuticals AG Corporation Information
11.9.2 Noorik Biopharmaceuticals AG Overview
11.9.3 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Noorik Biopharmaceuticals AG Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Noorik Biopharmaceuticals AG Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Overview
11.10.3 Novartis AG Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Novartis AG Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis AG Recent Developments
11.11 Opsona Therapeutics Limited
11.11.1 Opsona Therapeutics Limited Corporation Information
11.11.2 Opsona Therapeutics Limited Overview
11.11.3 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Opsona Therapeutics Limited Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Opsona Therapeutics Limited Recent Developments
11.12 OSE Immunotherapeutics
11.12.1 OSE Immunotherapeutics Corporation Information
11.12.2 OSE Immunotherapeutics Overview
11.12.3 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 OSE Immunotherapeutics Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 OSE Immunotherapeutics Recent Developments
11.13 Pharmicell
11.13.1 Pharmicell Corporation Information
11.13.2 Pharmicell Overview
11.13.3 Pharmicell Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pharmicell Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pharmicell Recent Developments
11.14 Pharming Group N.V.
11.14.1 Pharming Group N.V. Corporation Information
11.14.2 Pharming Group N.V. Overview
11.14.3 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pharming Group N.V. Kidney Transplant Rejection Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pharming Group N.V. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Kidney Transplant Rejection Therapeutics Industry Chain Analysis
12.2 Kidney Transplant Rejection Therapeutics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Kidney Transplant Rejection Therapeutics Production Mode & Process
12.4 Kidney Transplant Rejection Therapeutics Sales and Marketing
12.4.1 Kidney Transplant Rejection Therapeutics Sales Channels
12.4.2 Kidney Transplant Rejection Therapeutics Distributors
12.5 Kidney Transplant Rejection Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Kidney Transplant Rejection Therapeutics Industry Trends
13.2 Kidney Transplant Rejection Therapeutics Market Drivers
13.3 Kidney Transplant Rejection Therapeutics Market Challenges
13.4 Kidney Transplant Rejection Therapeutics Market Restraints
14 Key Findings in The Global Kidney Transplant Rejection Therapeutics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer